RAAPID Launches the First Autonomous Novel Clinical AI Platform to Power Risk Adjustment and Value-Based Care

September 03, 2025 at 08:00 AM EDT

Powered by Neuro-Symbolic AI, It Delivers a Quantum Leap in Speed, Value, and Accuracy for Health Plans & Health Systems

RAAPID Inc., a Microsoft M12-backed leader in AI-powered risk adjustment solutions, today announced a quantum leap in its retrospective risk adjustment platform, now powered by its new Novel Clinical AI engine to Automate Retrospective Reviews. The platform, powered by its proprietary Novel Clinical AI, is designed to meet the growing demands of value-based care by delivering an industry-shattering 92%+ out-of-the-box accuracy, which rises to over 98% with final coder validation. and enabling productivity gains of 60-80% for coding teams.

This launch marks a defining moment for health plans and health systems struggling with RADV audits and retrospective chart reviews. RAAPID's enhanced solution represents a true paradigm shift, built on the company's proprietary Neuro-Symbolic AI technology. Unlike traditional NLP, RAAPID's platform provides a transparent and explainable audit trail with precise clinical evidence for every suggested HCC code, creating a future-proof defense against audits and ensuring that payment aligns with the population's true needs.

"We're giving our clients the power to transform their risk adjustment operations and fully support their value-based care initiatives," said Chetan Parikh, CEO of RAAPID. "This is a fundamental transformation. We are delivering 92%+ out-of-the-box accuracy—not an incremental gain, but a significant improvement over the industry's 20-30% accuracy. Health plans and health systems can finally stop drowning in manual chaos and start commanding their entire risk adjustment program with confidence, backed by defensible accuracy."

The solution directly addresses the multi-million-dollar RADV audit clawbacks that haunt every CFO. By creating a single source of truth with MEAT-based evidence for every code, RAAPID enables a defensible accuracy that withstands the strictest audits and helps drive a revenue & RAF uplift of 10% or more.

RAAPID’s New Standard for Risk Adjustment

Accuracy: Achieve 92%+ coding accuracy right out of the box versus the 20-30% industry standard.
Productivity: Transform operations with a 5x+ productivity gain, freeing coding teams from manual drudgery.
Efficiency: Reduce per-chart review time from 30-40+ minutes to under 8 minutes, eliminating review marathons.
Transparency: Get explainable, auditable evidence for every code, building confidence and protecting against RADV clawbacks.

"We've supercharged our proven retrospective platform with our Novel Clinical AI engine to deliver something the industry has never seen," said Michael Clark, President & Chief Growth Officer of RAAPID. "This evolution represents our commitment to future-proofing risk adjustment. We're giving our clients' expert teams their lives back, transforming them from data cleaners into strategic leaders who focus on what matters most."

The RAAPID platform is HITRUST-certified and integrates seamlessly through cloud-based APIs, delivering immediate value without the headaches of implementation. As a Microsoft Pegasus partner with deployment options directly in clients' Azure environments, RAAPID ensures PHI never leaves the organization's control.

Health plans and Health Systems ready to experience the quantum leap can schedule a demo at https://www.raapidinc.com/contact-us/.

About RAAPID Inc.

RAAPID develops AI-powered risk adjustment solutions for healthcare payers, providers, and supporting organizations. The company's HITRUST-certified platform uses neuro-symbolic AI to identify chronic conditions, determine HCC codes, calculate risk scores, and analyze population health trends. Following a Series A investment from M12 (Microsoft's venture fund), RAAPID serves organizations participating in Medicare Advantage, ACA, Medicare ACO, and Medicaid programs. Founded by healthcare technology veterans with over 20 years of experience, RAAPID is headquartered in Louisville, Kentucky.